Prelude Capital Management, LLC Amarin Corp Plcuk Call Options Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$1.13 - $3.69 $11,751 - $38,376	-10,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $29,640 - $38,792	10,400 New	10,400 $34,000
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $69,438 - $105,950	-16,300 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $7,042 - $12,320	-1,400 Reduced 7.91%	16,300 $101,000
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $6,868 - $9,027	1,700 Added 10.63%	17,700 $87,000
Q3 2020 Nov 16, 2020	BUY	$3.64 - $7.76 $36,764 - $78,376	10,100 Added 171.19%	16,000 $67,000
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $8,604 - $14,868	1,800 Added 43.9%	5,900 $41,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $28,400 - $152,863	-7,100 Reduced 63.39%	4,100 $16,000
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $153,340 - $265,320	11,000 Added 5500.0%	11,200 $240,000
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $563,934 - $940,296	-40,600 Reduced 99.51%	200 $3,000
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $663,816 - $836,808	40,800 New	40,800 $791,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.